tci Medicare Compliance & Reimbursement - 2004 Issue 27
COVERAGE: Injectible Cancer Drugs Put On Pass-Through List
Subscribe or sign in to view the full article.
Article Overview
This article explains a Medicare coverage and payment update from the Centers for Medicare & Medicaid Services involving new pass-through items effective July 1. It is useful for hospital outpatient billing, oncology, allergy/asthma-related drug administration, and anyone tracking CMS payment changes, transmittals, and temporary reimbursement status for newly added items.
Why This Topic Matters
Pass-through updates can affect whether providers receive temporary payment for newly added drugs and technology, as well as how claims or adjustment bills are handled during the initial coverage period. The article helps billing and reimbursement staff identify a recent CMS change and know where to look for associated guidance.
What You Will Learn
- What a Medicare pass-through payment update is addressing in general terms
- Which types of drugs and technology were added to the pass-through list
- Why the effective date and timing of claims matter for payment
- Where CMS implementation guidance for the update was published
Who Should Read This
- Hospital outpatient billers
- Oncology practice coders
- Reimbursement specialists
- Medicare compliance staff
- Pharmacy billing staff
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com